<DOC>
	<DOCNO>NCT00543777</DOCNO>
	<brief_summary>The goal clinical research study test accuracy magnetic resonance elastogram ( MRE ) 2-point dixon magnetic resonance imaging ( 2PD MRI ) use new computer software ( call `` phase correction algorithm '' ) patient might liver disease .</brief_summary>
	<brief_title>Magnetic Resonance Elastography 2-Point Dixon MR Imaging Techniques Diffuse Liver Disease</brief_title>
	<detailed_description>Finding liver damage early possible important . Traditionally , biopsy use purpose . Biopsies accurate check small part liver . Tissue fat liver stiffness common patient liver disease.This study test new MRI technique ( call MRE ) may able test symptom entire liver , short time . A typical MRI use large magnet instead x-ray take picture inside body . The MRE do standard MRI scanner . Study Visit : The MRE procedure useful identify tissue stiffness . For MRE procedure , lie back examination table , pneumatic driver ( light-weight , clear plastic drum , 10 inch wide 1 inch thick ) place upper abdomen . You feel vibration ( like cell phone beeper vibrate ) . This vibration create small wave body . The scanner receive vibration liver use create image liver tissue . The MRE take 40 second . The driver turn time . Once MRE complete , 2PD MRI scan still lie table . This procedure useful identify fat tissue . This take 20-60 second . The total exam time 20 minute , include preparation time . Once MRI complete , liver biopsy part standard care . You sign separate consent form procedure . After biopsy perform , participation study complete . This investigational study . The scanner software 2PD MRI use study FDA-approved use clinical practice . The MRE technique use study FDA-approved . At time , MRE technique use research . The use study data purpose study investigational . Up 60 patient take part study . All enrol M. D. Anderson .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>1 . Group 1 . Nononcologic patient VAMC Houston : 2 . Biopsy proven clinically suspect advanced parenchymal liver disease 3 . Core biopsy obtain within 1month MRI/MRE 4 . No treatment affect status liver MRI/MRE postimaging biopsy 5 . Signed consent 6 . Group 2 . Oncologic patient MDACC : 7 . Clinically radiographically suspect liver damage , hepatic steatosis , hepatitis , hepatic fibrosis cirrhosis 8 . Surgical core biopsy schedule within 4 week MRI/MRE 9 . Signed consent 1 . Claustrophobia 2 . Contraindications MRI 3 . Unable hold breath 4 . Ascites clinical radiographical sign portal hypertension</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Liver Cancer</keyword>
	<keyword>Magnetic Resonance Elastography</keyword>
	<keyword>2-Point Dixon Magnetic Resonance Imaging</keyword>
	<keyword>Liver Disease</keyword>
	<keyword>Fatty Liver</keyword>
	<keyword>Liver Fibrosis</keyword>
	<keyword>Liver Cirrhosis</keyword>
	<keyword>MRE</keyword>
	<keyword>2PD MRI</keyword>
	<keyword>phase correction algorithm</keyword>
</DOC>